Roche And Shandong Gallo Virology Institute To Establish Gene Diagnostics Center
This article was originally published in PharmAsia News
Executive SummaryRoche Diagnostics APAC and Shandong Academy of Medical Sciences' Gallo Virology Institute recently established China's first personalized gene diagnostics center. The facility will provide personalized medicine and technologies to fight HIV/AIDS and other viral infectious diseases to meet medium- and long-term demands of the changing healthcare market in China. Both parties also signed a letter of intent to jointly conduct research in the field of diagnostics. Personalized medical care is a core strategy for Roche globally. With such solutions, physicians can conduct molecular testing and offer patients the most efficient and appropriate treatment programs. (Click here for more - Chinese Language)
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.